ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
GLAXOSMITHKLINE PHARMACEUTICALS disclosed its shareholding pattern as per regulatory requirements. No monetary or transactional event was announced.
GlaxoSmithKline Pharmaceuticals submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's ESG performance, safety standards, and community initiatives.
GlaxoSmithKline Pharmaceuticals filed its Annual Secretarial Compliance Report for FY2026 showing full regulatory adherence. No fines or observations were reported by the practicing company secretary.
GlaxoSmithKline Pharmaceuticals Ltd has authorized specific personnel, including the Managing Director and CFO, to determine the materiality of events for disclosure under SEBI Regulations. This administrative update ensures compliance with Regulation 30(5) regarding timely communication to stock exchanges.